Paxman ABPXMBF 74 Gross Margin % is 66.44% as of Mar. 2026, which is 4% below its 10-year median of 69.51. GuruFocus rates PXMBF with a GF Score™ of 74/100 and a GF Value™ of $4.25. The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Paxman AB ranks better than 73.91% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Paxman AB's Gross Profit for the
three
months ended in Mar. 2026 was $6.39 Mil. Paxman AB's Revenue for the
three
months ended in Mar. 2026 was $9.61 Mil. Therefore, Paxman AB's Gross Margin % for the quarter that ended in Mar. 2026 was 66.44%.
The historical rank and industry rank for Paxman AB's Gross Margin % or its related term are showing as below:
PXMBF'
s Gross Margin % Range Over the Past 10 Years
Min: 64.94 Med: 69.51 Max: 80.78
Current: 66.65
During the past 9 years, the highestGross Margin % of Paxman AB was 80.78%. The lowest was 64.94%. And the median was 69.51%.
PXMBF's Gross Margin % is ranked better than 73.91% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs PXMBF: 66.65
Paxman AB had a gross margin of 66.44% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Paxman AB was 0.70% per year.
Paxman AB (OTCPK:PXMBF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Paxman AB had a gross margin of 66.44% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Paxman AB Gross Margin % Related Terms
Paxman AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Paxman AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Paxman AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paxman AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Paxman AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Paxman AB (PXMBF) has a Gross Margin % of 66.44% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Paxman AB and its competitors. This is near median its historical median of 69.51. Over the past decade, Paxman AB's Gross Margin % has ranged from 64.94 to 80.78. According to the industry distribution chart, Paxman AB ranks #210 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 26.1%.
Is Paxman AB's Gross Margin % too high?
Paxman AB's current Gross Margin % of 66.44% is near median its 10-year median of 69.51. Over the past 10 years, this metric has ranged from a low of 64.94 to a high of 80.78. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Paxman AB's value of 66.44% is 27.6% above this industry median. Based on the distribution chart, Paxman AB ranks #210 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Paxman AB has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Paxman AB's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Paxman AB ranks #210 out of 805 companies for Gross Margin %. This puts Paxman AB in the upper half of its industry. The industry median Gross Margin % is 52.07. Paxman AB's value of 66.44% is 27.6% above this benchmark. Historically, Paxman AB's own Gross Margin % has ranged from 64.94 to 80.78 over the past decade. While the company's 10-year median is 69.51 vs. the industry median of 52.07, Paxman AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paxman AB's current Gross Margin % of 66.44% is 27.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Paxman AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paxman AB's current Gross Margin % is 66.44%, which is near median its own 10-year median of 69.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paxman AB stock overvalued right now?
Paxman AB (PXMBF) has a current Gross Margin % of 66.44%. The stock's GF Value™ is $4.25, compared to a current price of $3.50 — trading 17.6% below its estimated fair value. The current Gross Margin % is 66.44%, which is near median its 10-year median of 69.51 and 27.6% above the Medical Devices & Instruments industry median of 52.07. Paxman AB's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Paxman AB (PXMBF), the current Gross Margin % is 66.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paxman AB (PXMBF) Overvalued in 2026?
Based on GuruFocus' analysis, Paxman AB stock appears to be undervalued.
The current stock price of $3.50 is trading 17.6% below its estimated GF Value™ of $4.25.
Key valuation signals for PXMBF:
Gross Margin %: 66.44% (near median its 10-year median of 69.51)
GF Value™: $4.25 vs. price of $3.50 (17.6% below fair value)
Industry Position: 27.6% above the Medical Devices & Instruments median (#210 of 805)
No single metric tells the full story. See the PXMBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.
74GF Score
Get the complete analysis for PXMBF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PXMBF has been successfully added to your 
